In 2004, Solexa acquired the company Manteia Predictive Medicine in order to gain a massivelly parallel sequencing technology based on "DNA Clusters", which involves the clonal amplification of DNA on a surface.
In 2004, Solexa acquired the company Manteia Predictive Medicine in order to gain a massivelly parallel sequencing technology invented in 1997 by Pascal Mayer and Laurent Farinelli. It is based on "DNA Clusters" or "DNA colonies", which involves the clonal amplification of DNA on a surface.